Real-time enrollment status for this gata2 deficiency clinical trial
Current Status
Recruiting
Checked: October 19, 2026 at 12:38 AM UTC
| NCT Number | NCT01905826 |
| Recruiting Status | Recruiting |
| Condition | GATA2 Deficiency |
| Phase | Clinical Trial |
| Target Enrollment | 600 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Last Updated on CT.gov | October 13, 2026 (6 days ago) |
As of October 19, 2026: Clinical trial NCT01905826 is currently recruiting participants. This clinical trial study for gata2 deficiency is actively seeking new participants at 1 location across the United States. The study is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT01905826 is actively recruiting participants as of October 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT01905826 was last updated 6 days ago (October 13, 2026). HelloStudys verifies this status automatically.